PAPER Hassani OK, Rymar VV, Nguyen KQ, Huo L, Cloutier JF, Miller FD, Sadikot AF
PAPER Sathya S, Shanmuganathan B, Balasubramaniam B, Balamurugan K, Devi KP
Phytol loaded PLGA nanoparticles regulate the expression of Alzheimer's related genes and neuronal apoptosis against amyloid-β induced toxicity in Neuro-2a cells and transgenic Caenorhabditis elegans.Food Chem Toxicol. 2019 Nov 14;:110962. PubMed: 31734340
PAPER Xiao B, He N, Wang Q, Cheng Z, Jiao Y, Haacke EM, Yan F, Shi F
Quantitative susceptibility mapping based hybrid feature extraction for diagnosis of Parkinson's disease.Neuroimage Clin. 2019 Nov 5;24:102070. PubMed: 31734535
PAPER Mateos MJ, Gastelum-Strozzi A, Barrios FA, Bribiesca E, Alcauter S, Marquez-Flores JA
A novel voxel-based method to estimate cortical sulci width and its application to compare patients with Alzheimer's disease to controls.Neuroimage. 2019 Nov 14;:116343. PubMed: 31734431
PAPER Henderson MX, Sengupta M, Trojanowski JQ, Lee VM31733655
PAPER Hassan R, Rabea AA, Ragae A, Sabry D
The prospective role of mesenchymal stem cells exosomes on circumvallate taste buds in induced Alzheimer's disease of ovariectomized albino rats: (Light and transmission electron microscopic study).Arch Oral Biol. 2019 Oct 31;110:104596. PubMed: 31734542
PAPER Münster Y, Keyvani K, Herring A31734318
PAPER Giangrasso DM, Furlong TM, Keefe KA
Characterization of striatum-mediated behavior and neurochemistry in the DJ-1 knock-out rat model of Parkinson's disease.Neurobiol Dis. 2019 Nov 15;134:104673. PubMed: 31734455
PAPER Soloveva MV, Jamadar SD, Velakoulis D, Poudel G, Georgiou-Karistianis N31734228
JOB 2019-11-18 Employer Rosalind Franklin University / The Chicago Medical School Principal Investigator Grace Stutzmann Contact email@example.com Description The Center for Neurodegenerative Disease and Therapeutics at the Rosalind Franklin ...
Blade Therapeutics, IncSouth San Francisco, United States
COMMENT This is an extraordinary study that provides a final piece of evidence for the causal involvement of microglia in Alzheimer’s disease. This work follows up a previous report from the same group, where the authors performed transcriptomic analysis of human ...
AstellasCambridge, United States
COMMENT The intriguing and encouraging results of the GV971 trial could be explained by an alternative—or perhaps additional—mechanism: the protective effect against AD might well be the consequence of the drug acting as an antiviral agent against HSV1, which has ...